NEC OncoImmunity AS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors (NCT05354323) | NEC OncoImmunity AS | 2022-05-05 |
Track NEC OncoImmunity AS automatically
Every clearance here is in the API, with alerts when new ones post.